Patents by Inventor Anuj Gaggar

Anuj Gaggar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
    Publication number: 20240269142
    Abstract: The present disclosure provides for the treatment and/or prevention of a hepatitis B viral infection by administering to a subject a combination therapy regimen including a toll-like receptor 8 (TLR8) modulator, a dsRNA, and a PD-1/PD-L1 inhibitor.
    Type: Application
    Filed: May 12, 2022
    Publication date: August 15, 2024
    Inventors: Daniel J. CLOUTIER, Simon P. FLETCHER, Phillip S. PANG, Jenny Ching-Min STANTON, Chin H. TAY, Anuj GAGGAR
  • Methods for treating hepatitis B virus infections using NS5A, NS5B or NS3 inhibitors
    Patent number: 11738013
    Abstract: Provided are methods for treating hepatitis B virus infections by administering a NS5A inhibitor, NS5B inhibitor, a NS3 inhibitor, or combinations thereof.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: August 29, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Anuj Gaggar, G. Mani Subramanian
  • METHODS FOR TREATING HEPATITIS B VIRUS INFECTIONS USING NS5A, NS5B OR NS3 INHIBITORS
    Publication number: 20220117952
    Abstract: Provided are methods for treating hepatitis B virus infections by administering a NS5A inhibitor, NS5B3 inhibitor, a NS3 inhibitor, or combinations thereof.
    Type: Application
    Filed: May 11, 2017
    Publication date: April 21, 2022
    Inventors: Anuj Gaggar, G. Mani Subramanian